Table 1 ESCC patient characteristics according to tumor stromal FN expression
From: Expression of fibronectin in esophageal squamous cell carcinoma and its role in migration
Characteristics | No. of patients | High stromal FN | Low stromal FN | P-value |
|---|---|---|---|---|
Gender | Â | Â | Â | 0.490 |
 Male | 55 | 27 (49.1%) | 28 (51.0%) |  |
 Female | 13 | 5 (38.5%) | 8 (61.5%) |  |
Age (years) | Â | Â | Â | 0.491 |
  ≤ 60 | 37 | 16 (43.2%) | 21 (56.8%) |  |
  > 60 | 31 | 16 (51.6%) | 15 (48.4%) |  |
Tumor differentiation | Â | Â | Â | 0.881 |
 Poor | 24 | 11 (45.8%) | 13 (54.2%) |  |
 Well+Moderate | 44 | 21 (47.7%) | 23 (52.3%) |  |
 pT status |  |  |  | 0.228 |
 T1 + T2 | 15 | 5 (33.3%) | 10 (66.7%) |  |
 T3 | 53 | 27(50.9%) | 26 (49.1%) |  |
Lymph node metastasis | Â | Â | Â | 0.032* |
 NO | 45 | 17 (37.8%) | 28 (62.2%) |  |
 YES | 23 | 15 (65.2%) | 8 (34.8%) |  |
TNM stage | Â | Â | Â | 0.169 |
 I + II | 46 | 19 (41.3%) | 27 (58.7%) |  |
 III + IV | 22 | 13 (59.1%) | 9 (40.9%) |  |